FDA alerts customers to affected B. Braun dialysis bloodline sets
An FDA early alert identifies three lots of Streamline Bloodline Set for Dialog+ after the manufacturer reported inadequate connector bonding.
What the record says
FDA’s page, current as of October 27, lists model SL-2010M2096 and lots A2600099, A2600128 and A2600136. The agency says B. Braun’s October 20 customer letter recommends ceasing use, quarantining and returning affected products.
According to the manufacturer’s account on FDA’s page, a missed assembly step may allow connectors to detach or leak during priming or dialysis. FDA says it is reviewing the potentially high-risk issue.
Source details and supporting locations.
Practical next step
Affected organizations should check FDA’s identifiers and manufacturer instructions.
Limits and what is not established
This notice concerns specified products and lots; it is not individual medical advice.
Sources checked October 28, 2026. Later notices may change instructions or arrangements.
Original sources
U.S. Food and Drug Administration: original information